Leon Fisher

Dr. Leon Fisher

Peninsula Health, Frankston, Victoria, Australia
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
LFLeon Fisher
Leon Fisher
AFAlexander Fisher
Alexander Fisher

1 June 2006 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
LFLeon Fisher
Leon Fisher
AFAlexander Fisher
Alexander Fisher
ATAndrew Thomson
Andrew Thomson

19 January 2009 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
LFLeon Fisher
Leon Fisher
DSDev Shankar Segarajasingam
Dev Shankar Segarajasingam
CSColin Stewart
Colin Stewart
WDW Bastiaan Deboer
W Bastiaan Deboer
IYIan Fuad Yusoff
Ian Fuad Yusoff

1 January 2016 in International Journal of Medical Sciences
Verified
Journal Article
Open access
AFAlexander Fisher
Alexander Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
LFLeon Fisher
Leon Fisher
PSPaul Smith
Paul Smith
Aim: To investigate the association of the neutrophil to lymphocyte ratio (NLR) at admission with presence of fracture, comorbid conditions, and its prognostic value for short-term outcomes in orthogeriatric patients.

1 July 2017 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
AFAlexander Fisher
Alexander Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
LFLeon Fisher
Leon Fisher
PSPaul Smith
Paul Smith
Purpose: To estimate the discriminative value of serum P1NP/βCTX ratio and albumin levels in hospitalized orthogeriatric patients with and without nonvertebral fractures. Methods: In 1,239 orthogeriatric patients (mean age 78.1±9.52 years, 69.1% women) including 854 (68.9%) with osteoporotic nonvertebral fractures (455 [36.7%] with hip fracture [HF]) and 385 (31.1%) without fractures, markers of bone formation (procollagen type 1 N-terminal propeptide [P1NP], osteocalcin [OC], and bone resorption (beta-C-terminal cross-linking telopeptide of type 1 collagen [βCTX]), indices of mineral metabolism, and parameters of liver and renal functions were assessed; data on clinical and laboratory characteristics were collected prospectively. Results: Both lower serum P1NP/βCTX ratio and albumin concentration (as continuous or categorical variables) were independently associated with fracture presence in multivariate logistic regressions. Compared with the highest P1NP/βCTX tertile, the prevalence of HF, after adjustment for multiple covariates, was 3-fold higher in the lowest tertile and 1.5 times higher in the middle tertile; presence of any fracture was 2.3- and 1.6-fold higher, respectively; patients with albumin levels in the lowest tertile had multivariate odds ratio (OR) of 4.6 for HF and 2.8 for any fracture, in the middle tertile the ORs were 2.2 and 1.3, respectively. The P1NP/βCTX <100.0 (median) and hypoalbuminemia (<33 g/L) demonstrated area under the curve values for HF of 0.802 and 0.806, respectively, and for any fractures of 0.711 and 0.706, respectively. When both characteristics were combined, the ORs for HF or any fracture, compared with the nonfractured group, were 7.8 and 3.2, respectively, with an accuracy of 79.6% and 71.6%, respectively. Conclusions: In orthogeriatric patients, both serum P1NP/βCTX ratio and albumin levels demonstrated an inverse dose–effect relationship with the prevalence of nonvertebral fractures and independently indicated fracture presence with acceptable discriminatory power. Lower P1NP/βCTX (<100) and hypoalbuminemia could be useful simple additive prognostic tools for fracture risk stratification in the elderly.

1 April 2018 in Injury
Verified
Journal Article
Closed access
AFAlexander Fisher
Alexander Fisher
LFLeon Fisher
Leon Fisher
WSWichat Srikusalanukul
Wichat Srikusalanukul
PSPaul N. Smith
Paul N. Smith